Your portfolio's
morning briefing.

Research quality companies. Identify buy zones. Earn income while you wait. Delivered by 10 AM ET.

49 investors already signed up

See what a briefing looks like →

What you'll get every morning

Actual briefing sections — generated by our AI pipeline for a real subscriber.

Morning Briefing
Your Portfolio • Today
GRADE: B+
VIX
18.5
SPY
$580 +0.2%
QQQ
$496 -0.1%
IWM
$205 -0.5%
Sample data — your briefing shows live prices updated daily
Executive Summary

Markets traded higher with tech leading — NVDA surged 3.2% on strong earnings guidance while broader indices held gains. Your portfolio grade improved to B+ with 8 positions averaging +0.45%. Concentration risk is moderate at 22% in NVDA; consider trimming to 15% and redeploying into healthcare. Options premiums are attractive with VIX at 18.5 — the AAPL $260 covered call offers 17.5% annualized yield.

Recommended Actions
1. Trim NVDA from 22% to 15%, redeploy into XLV
2. Consider AAPL $260 covered call (34 DTE, $4.20 premium, 18% annualized)
3. Monitor AMD for buy zone signal near $163 — RSI oversold at 28
Options Income
5 symbols scanned
Covered Calls
Symbol Strike Exp Premium Ann. Yield Score
AAPL
Premium elevated vs. typical
$260 Apr 17 $4.20 18% 8/10
NVDA
Premium elevated vs. typical
$185 Apr 17 $5.80 34% 7/10
Est. Monthly Income: ~$785 on $50K portfolio
+ Portfolio Snapshot, Holdings, Earnings Watch, Volume Alerts... Get yours free
+6.2% median alpha at 6 months · 65.5% beat SPY · 54 stocks backtested · Updated weekdays

Join 49 investors getting daily briefings

+6.2% Median Alpha vs SPY (6 months) Quality at a Discount buy signal
65.5% Beat SPY Rate (29 signals)
71.6% Options Success Rate (2961 positions)
29 Signals Tested (54 stocks)
Backtested against 4 years of S&P 500 data AI-driven narratives & valuation signals Free — no credit card required
BACKTESTED

Our volatility-aware options income strategy

Sell premium only when option premiums are elevated vs. the stock's typical range. Backtested over 180 days across 93 stocks — 2,961 simulated positions.

65.8% CSP Success Rate 609 put contracts analyzed
73.0% CC Success Rate 2,352 call contracts analyzed
$907/mo Est. Income on $50K 3 positions, monthly cycles

See every position →

Past performance does not guarantee future results. Simulated backtest — not live trading.

Built for long-term investors who buy quality companies

Portfolio-Focused

Analysis based on your holdings — not generic market commentary. See how market moves affect the stocks you track.

See a live example →

Portfolio Doctor

A daily health checkup for your portfolio — sector concentration, earnings risk, RSI extremes, valuation gaps, and an overall A-through-F grade. Personalized diagnostics no generic newsletter can match.

See a sample report →

Quality at a Discount

A-rated companies trading below their 3-year valuation median. Conviction-scored buy signals with AI-generated thesis — no day-trading noise.

Options Income Overlay

Covered call and cash-secured put opportunities screened from real options chains. Premium yields and probability of profit included.

Deep Research

AI-generated research pages for every stock you track — fair value estimates, bull/bear scenarios, analyst consensus, and valuation regime. Updated continuously.

Browse research →

10 AM ET, Every Market Day

In your inbox by 10 AM ET. Scan in 2 minutes, act with confidence. No noise, just insight.

Free research on the stocks investors care about

View all research →
AAPL
Apple Inc.
+68.0%
NVDA
NVIDIA Corporation
High +59.3%
MSFT
Microsoft Corporation
+23.0%
AMZN
Amazon.com, Inc.
+32.0%
GOOGL
Alphabet Inc.
+23.3%
META
Meta Platforms, Inc.
+117.9%
XOM
Exxon Mobil Corporation
-37.3%
V
Visa Inc.
High +37.7%

How it works

  1. Sign up with your email

    Takes 10 seconds. No credit card required.

  2. Add your tickers

    Tell us what you own or watch. Up to 25 stocks (50 on Pro).

  3. Get your briefing

    Every weekday at 10:00 AM ET. AI analysis, valuation signals, options ideas.

Frequently Asked Questions

Personalized to YOUR holdings, not generic market news. Every section — executive summary, buy signals, options income — is tailored to the tickers you track. The AI narrative is written about your portfolio, not the S&P 500.

Every weekday at 10:00 AM ET — 30 minutes into the trading session, so your briefing includes live market data.

Up to 25 on the free plan, 50 on Pro. Add or change them anytime from your setup page.

Yes. The free plan includes daily briefings, buy signals, and top income opportunities. Pro ($9/mo) unlocks more tickers and full options coverage. See /pricing for details.

Coming soon. For now you get the full briefing — executive summary, buy signals, options income, portfolio health, and more.

A personalized portfolio health report in every briefing. Portfolio Doctor analyzes your holdings across six dimensions — sector concentration, earnings risk, RSI extremes, analyst consensus, valuation, and weighted upside — and gives you an overall health grade (A through F) with plain-English diagnostics. Think of it as a daily checkup for your portfolio, not just your stocks. See a sample report.

Quality at a Discount buy/add signals when A-rated companies are priced below their 3-year valuation median with strong revenue growth and analyst consensus. Plus trim signals when holdings become overvalued (>130% of median). Each signal includes valuation context, conviction score, and an AI-generated thesis.

A valuation-first approach: we find A-rated companies (FMP rating A- or higher) trading below their 3-year valuation median. Quality gates — positive revenue growth, strong analyst consensus, and minimum market cap — filter out value traps. The result: fundamentally strong businesses at historically attractive prices.

Backtested against 4 years of S&P 500 data (54 stocks, 2021–2025). Our primary buy signal delivered +6.2% median alpha vs SPY at 6 months. The trim signal validated sell discipline with −4.5% alpha.

Every opportunity is scored on five factors: how far out-of-the-money the strike is (delta — the option's sensitivity to stock price, used here as a rough proxy for the chance the option finishes worthless), premium yield, probability of profit, how elevated implied volatility (IV — the market's forecast of how much the stock will move, the main driver of how rich premiums are) is relative to historical levels, and where IV ranks over the past year. We backtest across 93 symbols over 6 months and the combined success rate is 71.6%. Covered calls require the stock to be above its 50-day trend, and cash-secured puts must be near a support level. Any symbol with a success rate below 50% is automatically disqualified. See the full options scorecard for complete transparency.

No. QuantHub provides educational and informational content only. We are not a registered investment advisor and nothing here constitutes personalized investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Real-time market data from professional-grade providers: Financial Modeling Prep for quotes, fundamentals, and technical indicators, and MarketData.app for live options chains with full greeks. AI analysis is powered by frontier language models. All data is refreshed daily before each briefing is generated.

Yes. Each recommendation includes the strike price, expiration date, premium, and probability of profit, along with a plain-English explanation of why the opportunity makes sense right now. Management rules — when to close for profit or cut losses — are attached to every opportunity. The scorecard shows full historical transparency so you can see exactly how past opportunities performed. If you're just getting started, begin with covered calls on stocks you already own.

There's a one-click unsubscribe link at the bottom of every email. No questions asked, instant removal.

Built by Suneet, a software engineer and long-term investor who got tired of reading generic market recaps that had nothing to do with his actual portfolio. QuantHub started as a personal tool — now it's yours too.

Stop reading generic market news.

Get intelligence that's actually about your money.